Search for: "EMAS, Inc." Results 21 - 40 of 41
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Sep 2014, 10:29 pm by Ben Vernia
(EMA), a Maryland not-for-profit corporation that owns skilled nursing facilities, has agreed to pay $1.3 million to the government for submitting false claims to Medicare for unreasonable or unnecessary rehabilitation therapy purportedly provided by RehabCare Group East Inc., a subsidiary of Kindred Healthcare Inc [read post]
26 Dec 2012, 1:35 pm by Tom Lamb
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa  (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
15 Apr 2012, 6:17 pm by Rebecca Shafer, J.D.
    Note: If your company has any developments you'd like to share, please send them to us at: RShafer@ReduceYourWorkersComp.com         Author Rebecca Shafer, JD, President of Amaxx Risk Solutions, Inc. is a national expert in the field of workers compensation. [read post]
4 Apr 2012, 9:12 am
EMA which clearly granted First Amendment protection to video games. [read post]
2 Jan 2012, 8:00 am by Gordon Firemark
EMA THREsq: http://www.hollywoodreporter.com/thr-esq/supreme-court-strikes-down-california-205827 4. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's Generic Yaz(R) Receives FDA Approval", which begins as follows: Watson Pharmaceuticals, Inc. [read post]
10 Aug 2011, 4:30 am by Marie Louise
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
5 Aug 2011, 2:27 pm by Tom Lamb
European Drug Regulator EMA Recommended New Actos Contra-Indications And Warnings In July 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On August 4, 2011 we learned that Takeda Pharmaceuticals America, Inc. had revised the prescribing information -- also called the package insert or label -- for its diabetes drug Actos (pioglitazone) and other anti-diabetic pioglitazone-containing medicines by means of this item, "FDA Drug Safety Communication: Updated drug labels for… [read post]
22 Jul 2011, 2:34 pm by Tom Lamb
"  (8/4/11, Health Canada MedEffect e-Notice) Multaq (dronedarone), Sanofi-aventis Canada Inc., must not be prescribed to patients with permanent atrial fibrillation. [read post]
30 Jun 2011, 7:53 am by Conor McEvily
”  ACSblog links to an analysis of the Court’s recent decision in in Janus Capital Group, Inc. v. [read post]
8 Dec 2010, 2:20 am by Marie Louise
Bulgarian Patent Office (Kluwer Patent Blog) Canada: World AIDS Day brings calls for legislative caution, reform (IP Watch) EU: EMA publishes guidelines for biosimilar antibodies (Part I – Patent Docs), (Part II – Patent Docs) EU: AstraZeneca and Nycomed raid by EU antitrust officials (GenericsWeb) India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) India: Demand for changes in patent… [read post]
23 Jun 2009, 7:47 pm
  Bryan has previously blogged about EMA,. or economically motivated adulteration. [read post]